Highnoon Laboratories Announces Board’s Approval of 2nd Quarter Financial Statements

Karachi, Highnoon Laboratories Limited has taken a significant step towards financial transparency and reporting by securing the Board of Directors’ approval for its 2nd Quarter financial statements. The decisive meeting was held on August 15, 2023, in Dubai, UAE. These financial statements encompass the period ending on June 30, 2023, and include both the company’s standalone financial results and its consolidated financial results in conjunction with its subsidiary.

The company’s operating performance is reflected in the unconsolidated condensed interim statement of profit or loss, as well as the consolidated condensed interim statement of profit or loss, demonstrating the company’s earnings, costs, and profits.

The quarterly report for the period ended June 30, 2023, will be disseminated through PUCARS separately, upholding the company’s commitment to timely disclosure.

The post Highnoon Laboratories Announces Board’s Approval of 2nd Quarter Financial Statements appeared first on Pakistan Company News.